Cuscal (CCL) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
20 Oct, 2026Meeting business
Shareholders were asked to receive and consider the Financial Report, Directors’ Report, Sustainability Report and Independent Auditor’s Report for FY ended 30 June 2026.
The meeting considered a non-binding ordinary resolution to adopt the FY2026 Remuneration Report.
Ordinary resolutions proposed the elections of Peter Wright and Leila Fourie as directors.
Shareholder approval was sought to grant Craig Kennedy 254,978 performance rights under the LTI Plan for his FY27 long-term incentive, including the transfer or allocation of securities on vesting.
Proxy and direct voting
Remuneration Report adoption received 115,145,711 votes for (97.91%), 2,429,830 against (2.07%) and 30,619 undirected (0.03%); total 117,606,160.
Peter Wright’s election received 118,774,530 votes for (99.97%), 9,877 against (0.01%) and 30,619 undirected (0.03%); total 118,815,026.
Leila Fourie’s election received 118,711,827 votes for (99.91%), 72,580 against (0.06%) and 30,619 undirected (0.03%); total 118,815,026.
The FY27 LTI performance-rights grant received 115,752,618 votes for (98.25%), 2,029,069 against (1.72%) and 30,619 undirected (0.03%); total 117,812,306.
Latest events from Cuscal
- Underlying NOI and NPAT up 20%, statutory NPAT up 49%, with strong FY27 growth outlook.CCL
H2 2026 - Profit up 21% to $31.6m, dividend increased, and IPO targeted for late 2024.CCL
H2 2024 - NPAT up 76% to $21.5m, Indue boosts income, and outlook raised for mid-teens growth.CCL
H1 2026 - Pro forma NPAT up 42% to $21.5m, EBITDA up 21%, and transaction volumes up 7% in H1 FY25.CCL
H1 2025 - Strong H1 FY25 growth and innovation position the business for further expansion.CCL
ASX SMIDcaps Conference Presentation - FY25 NPAT beat forecasts; Indue acquisition to deliver major synergies and EPS growth.CCL
H2 2025